Laboratory Medicine in Diabetic Kidney Disease (Ongoing)

Posted On 2020-12-03 10:25:49



This Series on “Laboratory Medicine in Diabetic Kidney Disease” is edited by Dr. Rafael Noal Moresco from Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.

Rafael Noal Moresco, PhD
Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil

Dr. Moresco graduated in Pharmacy and Biochemistry from the Pontifical Catholic University of Rio Grande do Sul (Brazil) in 2000. He received his Master Degree in Medicine from Federal University of Rio Grande do Sul (Brazil) in 2003 and Doctorate Degree in 2005. He completed his postdoctoral at Ghent University (Belgium) in 2015.

Dr. Moresco is currently an Associate Professor of Clinical Biochemistry at the Department of Clinical and Toxicological Analysis, Federal University of Santa Maria, Brazil. His research interests are related to the development of studies including biomarkers used for diagnosis and prognosis of diseases, especially diabetes (and its chronic complications), renal and cardiovascular diseases. Dr. Moresco serves as scientific journal referee in 23 journals in the area. He has published more than 200 papers in the international peer-review journals and his H-index in Web of Science is 22.

Series outline:

  1. Serum creatinine and albuminuria: clinical and laboratory evidence for the investigation of diabetes kidney disease 
  2. Tubular markers useful for the assessment of diabetic kidney disease
  3. Clinical usefulness of inflammation and fibrosis markers for the investigation of diabetes kidney disease
  4. Can urinary sediment assist in the diagnosis of diabetic kidney disease?
  5. The role of glycated albumin in diabetic kidney disease
  6. Posttranslational modifications of proteins and kidney disease in diabetes
  7. Urinary proteomics in diabetic kidney disease
  8. Markers of nucleic acid oxidation in diabetic kidney disease
  9. The role of epigenetic markers in the investigation of diabetes kidney disease

Disclosure:
The series “Laboratory Medicine in Diabetic Kidney Disease” was commissioned by the editorial office, Journal of Laboratory and Precision Medicine without any sponsorship or funding. Rafael Noal Moresco is serving as the unpaid Guest Editor for the series.